跳至主要内容
临床试验/NCT06860568
NCT06860568已完成不适用

Annotation of Geographic Atrophy in Hyperspectral Images Captured With the Optina-4C™

Optina Diagnostics Inc.1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年12月24日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
试验地点
1
主要终点
Comparison of the total number of Relspec images annotated for GA lesions

研究概览

简要总结

This study used a retrospective dataset collected by Optina under different study protocols. The target study population will include adults over the age of 50 years, with and without the presence of AMD.

详细描述

This retrospective, case-control study used the clinical data previously collected by Optina (CIP 22-003 AND Study, CIP 22-004 CAS Training Study and RWD 24-011 RWD Study). As such, no new participants were enrolled for this study. The review and annotation of the MHRC H5 Images for GA are within the scope of each of these studies and the study participants have provided their Informed Consent for use of their retinal scans to assess clinical diagnostic applications. Images from the above-mentioned studies that met the inclusion criteria (there were no exclusion criteria) were classified into 3 different cohorts per the selection process described in the Study Protocol. Each cohort required a minimum of 10 MHRC Images from unique eyes with matched OCT scans.

  • Cohort A: Eyes of patients with a diagnosis of dry AMD with GA lesions:

o This cohort included patients with intermediate-or late-stage dry AMD where GA lesions are present, based on either the diagnostic information provided by the clinic, or by visible assessment of either the HSI or OCT images performed by the Optina Analyst.

  • Cohort B: Eyes of patients with diagnosis of dry AMD without the presence of GA lesions

o This cohort included patients with early or intermediate dry AMD where GA lesions are not present, based on either the diagnostic information provided by the clinic, or by visible assessment of either the HSI or OCT images performed by the Optina Analyst.

  • Cohort C: Eyes of age-matched healthy patients (no AMD or GA lesions)

  • This cohort included patients with healthy retinas, based on either the diagnostic information provided by the clinic, or by visible assessment of either the HSI or OCT images performed by the Optina Analyst. Knowledge Transfer and Training Optina facilitated a Knowledge Transfer and Training session by the IOI for CapeStart Study Personnel.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants may enter the study only if ALL the following inclusion criteria are present:
  • Study participants over the age of 50 years who consented to participate in Optina studies CIP-22-003, CIP-22-004, DOC100463, or RWD-24-
  • MHRC H5 Image Cube has been reviewed by an Optina Analyst and identified as aligned with the Target Population (see Section 5.2).
  • MHRC H5 Image Cube has a corresponding OCT image.

排除标准

  • No exclusion criteria.

结局指标

主要结局

Comparison of the total number of Relspec images annotated for GA lesions

时间窗: 45 days

Comparison of the total number of Relspec images annotated for GA lesions of at least 29 pixels or larger with the total number of OCT images with identified GA lesions (cRORA) in the Test Dataset.

Comparison of the total number of 'high certainty' GA lesions

时间窗: 45 days

Comparison of the total number of 'high certainty' GA lesions (Yellow label) of at least 29 pixels annotated in all Relspec images with the total number of (cRORA) identified in the OCT images in the Test Dataset.

Comparison of the total number of GA lesions

时间窗: 45 days

Comparison of the total number of GA lesions (Yellow label and Dark Blue label) of at least 29 pixels or larger annotated in all Relspec images with the total number of identified GA lesions (cRORA) in the OCT images in the Test Dataset.

Evaluation of the Global DICE Score

时间窗: 45 days

Evaluation of the Global DICE Score for annotations of 29 pixels or larger performed by CapeStart compared with the Reference Data.

次要结局

未报告次要终点

研究者

发起方
Optina Diagnostics Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The GA in HSI Study | 临床试验